Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07735000) titled 'Effect of Trypan Blue on Corneal Endothelial Cell Count During Phacoemulsification' on July 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Hayat Abad Medical Complex, Peshawar
Condition:
Age Related Cataract
Cataract
Intervention:
Drug: Trypan Blue
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 22, 2024
Target Sample Size: 60
Countries of Recruitment:
Pakistan
To know more, visit https://clinicaltrials.gov/study/NCT07735000
Disclaimer: C...